Matwings

Matwings (天鹜科技) is an AI-driven, full-stack protein R&D and design platform that Qiming Venture Partners has backed and continued to fund — per Qiming's own commentary, it's the AI protein-design company in their portfolio alongside Insilico Medicine, and one they describe as drawing significant attention . In March 2026 it closed an A+ round of over RMB 200 million, with Qiming doubling down . On the team side, its chief scientist is Hong Liang, a distinguished professor at Shanghai Jiao Tong University , and its co-founder and CTO is Hao Liu . Its work sits at the intersection of AI, synthetic biology, and biomedicine — in November 2025 it signed a strategic partnership with Bayer Consumer Health at the China International Import Expo , and earlier that year it made the SAIL Award Top 30 list at the World Artificial Intelligence Conference .